نتایج جستجو برای: پوششهای rtv

تعداد نتایج: 697  

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2009
Vijay P Singh Gary D Bren Alicia Algeciras-Schimnich David Schnepple Sarah Navina Stacey A Rizza Rajinder K Dawra Ashok K Saluja Suresh T Chari Santhi S Vege Andrew D Badley

There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated mitochondrial dysfunction occurs during pancreatitis, and we have shown that PI prevents PTPC op...

2015
Seok-Gyu Kim Chae-Heon Chung Mee-Kyoung Son

PURPOSE The purpose of this study was to examine the abutment screw stability of screw- and cement-retained implant-supported dental prosthesis (SCP) after simulated cement washout as well as the stability of SCP cements after complete loosening of abutment screws. MATERIALS AND METHODS Thirty-six titanium CAD/CAM-made implant prostheses were fabricated on two implants placed in the resin mod...

2016
Sarah-Naomi. James Celeste H.M. Cheung Fruhling Rijsdijk Philip Asherson Jonna Kuntsi Celeste H. M. Cheung

Background: Cognitive theories of attention-deficit/hyperactivity disorder (ADHD) propose that high within-subject fluctuations of cognitive performance in ADHD, particularly reaction time (RT) variability (RTV), may reflect arousal dysregulation. Yet, direct evidence of arousal dysregulation and how it may account for fluctuating reaction times in ADHD is limited. We used skin conductance (SC)...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
Alan Winston Patrick W G Mallon Claudette Satchell Karen MacRae Kenneth M Williams Malte Schutz Matthew Law David A Cooper Sean Emery

BACKGROUND Toxicities observed with current combination antiretroviral therapy (CART) warrant a search for novel options, such as class-sparing regimens. Ritonavir-boosted double-protease inhibitor (PI)-only regimens are such an option but are prone to pharmacokinetic interactions. METHODS This 48-week randomized study examined the safety and efficacy of a switch in CART to a once-daily regim...

Journal: :Antiviral therapy 2011
John E McKinnon Rafael Delgado Federico Pulido Wei Shao Jose R Arribas John W Mellors

BACKGROUND Ritonavir-boosted lopinavir (LPV/RTV) alone has been evaluated as simplified maintenance therapy for HIV-1 infection, but there are concerns about greater potential for emergence of protease inhibitor (PI) resistance. The OK04 trial evaluated maintenance therapy with LPV/RTV alone versus standard therapy (ST) with two NRTIs plus LPV/RTV in 205 patients, of whom 15 had virological reb...

2017
Ilaria Bacigalupo Clelia Palladino Patrizia Leone Elena Toschi Cecilia Sgadari Barbara Ensoli Giovanni Barillari

A reduced incidence and decreased clinical progression of uterine cervical intraepithelial neoplasia (CIN) has been observed in women infected with human immunodeficiency virus (HIV) treated with HIV-protease inhibitors (PIs). The HIV-PIs saquinavir (SQV) and ritonavir (RTV) have been demonstrated to efficiently inhibit invasion of human primary CIN cells by downregulating the expression of mat...

2015
Qiang Liu Changfa Fan Shuya Zhou Yanan Guo Qin Zuo Jian Ma Susu Liu Xi Wu Zexu Peng Tao Fan Chaoshe Guo Yuelei Shen Weijin Huang Baowen Li Zhengming He Youchun Wang

Due to the increasing concern of using smallpox virus as biological weapons for terrorist attack, there is renewed interest in studying the pathogenesis of human smallpox and development of new therapies. Animal models are highly demanded for efficacy and safety examination of new vaccines and therapeutic drugs. Here, we demonstrated that both wild type and immunodeficient rats infected with an...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2010
Feng Li Laiyou Wang Grace L Guo Xiaochao Ma

Tipranavir (TPV) is the first nonpeptidic protease inhibitor used for the treatment of drug-resistant HIV infection. Clinically, TPV is coadministered with ritonavir (RTV) to boost blood concentrations and increase therapeutic efficacy. The mechanism of metabolism-mediated drug interactions associated with RTV-boosted TPV is not fully understood. In the current study, TPV metabolism was investi...

2015
Woong-Rae Cho Yoon-Hyuk Huh Chan-Jin Park Lee-Ra Cho

PURPOSE The aim of this study was to evaluate the effect of cyclic loading and screw retightening on reverse torque value (RTV) in external and internal type implants. MATERIALS AND METHODS Cement-retained abutments were connected with 30 Ncm torque to external and internal type implants. Experimental groups were classified according to implant connection type and retightening/loading protoco...

Journal: :The Journal of infectious diseases 2013
Pedro Cahn Omar Sued

For >15 years, ritonavir (RTV) has been the only pharmacokinetic enhancer (ie, booster) for human immunodeficiency virus (HIV) protease inhibitors. The development of cobicistat (COBI) promises to provide an alternative to RTV without direct antiviral effects of its own. COBI, a potent cytochrome P450 3A (CYP3A) inhibitor recently approved by the Food and Drug Administration (FDA) for use in a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید